Cargando…
Post nirmatrelvir/ritonavir erythema multiforme in a patient with coronavirus disease infection
Erythema multiforme (EM), an immune-mediated skin condition, can occur after infection or following the use of medications. In this study, we describe a patient who developed EM after nirmatrelvir/ritonavir administration. An 81-year-old woman presented with fever and dyspnea. Laboratory investigati...
Autores principales: | Tavares-Júnior, José Wagner Leonel, Pompeu, José Carlos Jucá, Galvão, Luiz Eduardo Garcia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Medicina Tropical - SBMT
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238063/ https://www.ncbi.nlm.nih.gov/pubmed/37283342 http://dx.doi.org/10.1590/0037-8682-0008-2023 |
Ejemplares similares
-
Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022) -
Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022) -
Nirmatrelvir/ritonavir as a possible treatment for Long-COVID
por: Catalán, Ignacio Pérez, et al.
Publicado: (2023) -
Nirmatrelvir Plus Ritonavir: First Approval
por: Lamb, Yvette N.
Publicado: (2022) -
Erythema multiforme in the context of SARS-Coronavirus-2 infection()
por: Sánchez-Velázquez, Alba, et al.
Publicado: (2020)